These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20169665)

  • 1. Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer.
    Michelsen TM; Tonstad S; Pripp AH; Tropé CG; Dørum A
    Int J Gynecol Cancer; 2010 Feb; 20(2):233-9. PubMed ID: 20169665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
    N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
    Terra L; Beekman MJ; Engelhardt EG; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; Van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; Aaronson NK; Mourits MJE; van Leeuwen FE
    Am J Obstet Gynecol; 2023 Apr; 228(4):440.e1-440.e20. PubMed ID: 36403862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cardiovascular disease after preventive salpingo-oophorectomy.
    Johansen N; Tonstad S; Liavaag AH; Selmer RM; Tanbo TG; Michelsen TM
    Int J Gynecol Cancer; 2020 May; 30(5):575-582. PubMed ID: 32332121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM; Dørum A; Dahl AA
    Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
    Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
    Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study.
    Michelsen TM; Pripp AH; Tonstad S; Tropé CG; Dørum A
    Eur J Cancer; 2009 Jan; 45(1):82-9. PubMed ID: 19008092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.
    Teixeira N; Mourits MJ; Oosterwijk JC; Fakkert IE; Absalom AR; Bakker SJL; van der Meer P; de Bock GH
    Fam Cancer; 2019 Jan; 18(1):19-27. PubMed ID: 29881922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.
    Michelsen TM; Dørum A; Tropé CG; Fosså SD; Dahl AA
    Int J Gynecol Cancer; 2009 Aug; 19(6):1029-36. PubMed ID: 19820364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM; Rebbeck TR
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
    Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
    Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
    Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
    Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.
    Finch A; Metcalfe K; Lui J; Springate C; Demsky R; Armel S; Rosen B; Murphy J; Elit L; Sun P; Narod S
    Clin Genet; 2009 Mar; 75(3):220-4. PubMed ID: 19263514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
    Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
    Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations.
    Swanson CL; Bakkum-Gamez JN
    Curr Treat Options Oncol; 2016 May; 17(5):20. PubMed ID: 27032642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.
    Shigehiro M; Kita M; Takeuchi S; Ashihara Y; Arai M; Okamura H
    Jpn J Clin Oncol; 2016 Mar; 46(3):254-9. PubMed ID: 26685323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.